1 | visits | 8,399 |
2 | appointments | 652 |
3 | check-ups | 114 |
4 | visitation | 112 |
5 | permanente | 103 |
6 | attenders | 90 |
7 | attendances | 89 |
8 | trips | 54 |
9 | z250 | 45 |
10 | z350 | 28 |
11 | tbbx | 18 |
12 | f/u | 17 |
13 | cystoscopies | 16 |
14 | vcugs | 16 |
15 | certifications | 15 |
16 | dispatches | 11 |
17 | fastrach™ | 11 |
18 | pro-seal | 11 |
19 | lifelink | 10 |
20 | ctrach | 8 |
21 | suctionings | 7 |
22 | re-presentations | 6 |
23 | visits/year | 6 |
24 | creations | 4 |
25 | non-achievers | 4 |
26 | renovations | 4 |
27 | amclc | 3 |
28 | cohabitations | 3 |
29 | visitations | 3 |
30 | warme-pflaster | 3 |
31 | z350xt | 3 |
32 | 474.9 | 2 |
33 | avaliada | 2 |
34 | enflurane | 2 |
35 | for/living | 2 |
36 | linkmen | 2 |
37 | monitoring® | 2 |
38 | nontonsillectomy | 2 |
39 | pickups | 2 |
40 | potion | 2 |
41 | pr=0.8 | 2 |
42 | secundines | 2 |
43 | supremes | 2 |
44 | test-results | 2 |
45 | vists | 2 |
46 | 1/3-esv | 1 |
47 | 2-4weeks | 1 |
48 | 2.04±0.5au | 1 |
49 | 2011/05/31 | 1 |
50 | 203568 | 1 |
51 | 26,003 | 1 |
52 | 3.7+/-1.6 | 1 |
53 | 3.9+/-1.8 | 1 |
54 | 38/49 | 1 |
55 | 54738 | 1 |
56 | 54739 | 1 |
57 | 730/158 | 1 |
58 | 9.0±2.6 | 1 |
59 | 99470 | 1 |
60 | affinity-cytochemistry | 1 |
61 | albumin-ima | 1 |
62 | anti-hiv-positive | 1 |
63 | assistant-written | 1 |
64 | assisted-large | 1 |
65 | audioscreener+ | 1 |
66 | awareness/training | 1 |
67 | bergson | 1 |
68 | betweenmarch | 1 |
69 | bounce-backs | 1 |
70 | bp≥50th | 1 |
71 | cows=37.9 | 1 |
72 | driggers | 1 |
73 | effort/accuracy | 1 |
74 | exercises.there | 1 |
75 | faustus | 1 |
76 | field-notes | 1 |
77 | filabavi | 1 |
78 | flaherty | 1 |
79 | group-membership | 1 |
80 | hobson | 1 |
81 | iassy | 1 |
82 | infratoxicity | 1 |
83 | inhalotherapy | 1 |
84 | interventions- | 1 |
85 | inventory-female | 1 |
86 | k4b | 1 |
87 | kochar | 1 |
88 | levret | 1 |
89 | mattison | 1 |
90 | measurings | 1 |
91 | mmses | 1 |
92 | monitoring®-system | 1 |
93 | n=2937 | 1 |
94 | non-responders/relapsers | 1 |
95 | null-responders/relapsers | 1 |
96 | occlusion/microembolization/reperfusion | 1 |
97 | ofophthalmology | 1 |
98 | orasis | 1 |
99 | paraclinoid | 1 |
100 | per-member-per-month | 1 |
101 | pr=1.2 | 1 |
102 | qibo | 1 |
103 | rechecks | 1 |
104 | reduzida | 1 |
105 | reoccluded | 1 |
106 | research-clinical | 1 |
107 | resting-fmri | 1 |
108 | revascularization-procedures | 1 |
109 | risks.evaluations | 1 |
110 | rsars | 1 |
111 | sbp-cvs | 1 |
112 | silorane® | 1 |
113 | smear/biopsy | 1 |
114 | som-asheville | 1 |
115 | staff.participants | 1 |
116 | subterritories | 1 |
117 | supreme-fs | 1 |
118 | supremext | 1 |
119 | tele-diagnosis | 1 |
120 | tempature | 1 |
121 | thelial-dependent | 1 |
122 | times-teachers | 1 |
123 | transition-optimizing | 1 |
124 | travell | 1 |
125 | uniquetm | 1 |
126 | use/type | 1 |
127 | uv-device | 1 |
128 | videovisits | 1 |
129 | wegman | 1 |
130 | z250,3m-espe | 1 |
131 | z250-fz | 1 |
132 | z350™ | 1 |
1 | 1/3-esv | 1 |
2 | 2-4weeks | 1 |
3 | 2.04±0.5au | 1 |
4 | 2011/05/31 | 1 |
5 | 203568 | 1 |
6 | 26,003 | 1 |
7 | 3.7+/-1.6 | 1 |
8 | 3.9+/-1.8 | 1 |
9 | 38/49 | 1 |
10 | 474.9 | 2 |
11 | 54738 | 1 |
12 | 54739 | 1 |
13 | 730/158 | 1 |
14 | 9.0±2.6 | 1 |
15 | 99470 | 1 |
16 | affinity-cytochemistry | 1 |
17 | albumin-ima | 1 |
18 | amclc | 3 |
19 | anti-hiv-positive | 1 |
20 | appointments | 652 |
21 | assistant-written | 1 |
22 | assisted-large | 1 |
23 | attendances | 89 |
24 | attenders | 90 |
25 | audioscreener+ | 1 |
26 | avaliada | 2 |
27 | awareness/training | 1 |
28 | bergson | 1 |
29 | betweenmarch | 1 |
30 | bounce-backs | 1 |
31 | bp≥50th | 1 |
32 | certifications | 15 |
33 | check-ups | 114 |
34 | cohabitations | 3 |
35 | cows=37.9 | 1 |
36 | creations | 4 |
37 | ctrach | 8 |
38 | cystoscopies | 16 |
39 | dispatches | 11 |
40 | driggers | 1 |
41 | effort/accuracy | 1 |
42 | enflurane | 2 |
43 | exercises.there | 1 |
44 | f/u | 17 |
45 | fastrach™ | 11 |
46 | faustus | 1 |
47 | field-notes | 1 |
48 | filabavi | 1 |
49 | flaherty | 1 |
50 | for/living | 2 |
51 | group-membership | 1 |
52 | hobson | 1 |
53 | iassy | 1 |
54 | infratoxicity | 1 |
55 | inhalotherapy | 1 |
56 | interventions- | 1 |
57 | inventory-female | 1 |
58 | k4b | 1 |
59 | kochar | 1 |
60 | levret | 1 |
61 | lifelink | 10 |
62 | linkmen | 2 |
63 | mattison | 1 |
64 | measurings | 1 |
65 | mmses | 1 |
66 | monitoring® | 2 |
67 | monitoring®-system | 1 |
68 | n=2937 | 1 |
69 | non-achievers | 4 |
70 | non-responders/relapsers | 1 |
71 | nontonsillectomy | 2 |
72 | null-responders/relapsers | 1 |
73 | occlusion/microembolization/reperfusion | 1 |
74 | ofophthalmology | 1 |
75 | orasis | 1 |
76 | paraclinoid | 1 |
77 | per-member-per-month | 1 |
78 | permanente | 103 |
79 | pickups | 2 |
80 | potion | 2 |
81 | pr=0.8 | 2 |
82 | pr=1.2 | 1 |
83 | pro-seal | 11 |
84 | qibo | 1 |
85 | re-presentations | 6 |
86 | rechecks | 1 |
87 | reduzida | 1 |
88 | renovations | 4 |
89 | reoccluded | 1 |
90 | research-clinical | 1 |
91 | resting-fmri | 1 |
92 | revascularization-procedures | 1 |
93 | risks.evaluations | 1 |
94 | rsars | 1 |
95 | sbp-cvs | 1 |
96 | secundines | 2 |
97 | silorane® | 1 |
98 | smear/biopsy | 1 |
99 | som-asheville | 1 |
100 | staff.participants | 1 |
101 | subterritories | 1 |
102 | suctionings | 7 |
103 | supreme-fs | 1 |
104 | supremes | 2 |
105 | supremext | 1 |
106 | tbbx | 18 |
107 | tele-diagnosis | 1 |
108 | tempature | 1 |
109 | test-results | 2 |
110 | thelial-dependent | 1 |
111 | times-teachers | 1 |
112 | transition-optimizing | 1 |
113 | travell | 1 |
114 | trips | 54 |
115 | uniquetm | 1 |
116 | use/type | 1 |
117 | uv-device | 1 |
118 | vcugs | 16 |
119 | videovisits | 1 |
120 | visitation | 112 |
121 | visitations | 3 |
122 | visits | 8,399 |
123 | visits/year | 6 |
124 | vists | 2 |
125 | warme-pflaster | 3 |
126 | wegman | 1 |
127 | z250 | 45 |
128 | z250,3m-espe | 1 |
129 | z250-fz | 1 |
130 | z350 | 28 |
131 | z350xt | 3 |
132 | z350™ | 1 |
1 | audioscreener+ | 1 |
2 | interventions- | 1 |
3 | z250 | 45 |
4 | z350 | 28 |
5 | 99470 | 1 |
6 | 2011/05/31 | 1 |
7 | pr=1.2 | 1 |
8 | 26,003 | 1 |
9 | 3.7+/-1.6 | 1 |
10 | 9.0±2.6 | 1 |
11 | n=2937 | 1 |
12 | pr=0.8 | 2 |
13 | 3.9+/-1.8 | 1 |
14 | 54738 | 1 |
15 | 730/158 | 1 |
16 | 203568 | 1 |
17 | 474.9 | 2 |
18 | cows=37.9 | 1 |
19 | 54739 | 1 |
20 | 38/49 | 1 |
21 | avaliada | 2 |
22 | reduzida | 1 |
23 | albumin-ima | 1 |
24 | k4b | 1 |
25 | amclc | 3 |
26 | reoccluded | 1 |
27 | paraclinoid | 1 |
28 | uv-device | 1 |
29 | assisted-large | 1 |
30 | inventory-female | 1 |
31 | som-asheville | 1 |
32 | enflurane | 2 |
33 | z250,3m-espe | 1 |
34 | use/type | 1 |
35 | exercises.there | 1 |
36 | tempature | 1 |
37 | permanente | 103 |
38 | anti-hiv-positive | 1 |
39 | awareness/training | 1 |
40 | for/living | 2 |
41 | transition-optimizing | 1 |
42 | ctrach | 8 |
43 | betweenmarch | 1 |
44 | bp≥50th | 1 |
45 | per-member-per-month | 1 |
46 | resting-fmri | 1 |
47 | filabavi | 1 |
48 | lifelink | 10 |
49 | research-clinical | 1 |
50 | pro-seal | 11 |
51 | travell | 1 |
52 | monitoring®-system | 1 |
53 | uniquetm | 1 |
54 | wegman | 1 |
55 | linkmen | 2 |
56 | assistant-written | 1 |
57 | occlusion/microembolization/reperfusion | 1 |
58 | visitation | 112 |
59 | potion | 2 |
60 | hobson | 1 |
61 | bergson | 1 |
62 | mattison | 1 |
63 | qibo | 1 |
64 | group-membership | 1 |
65 | visits/year | 6 |
66 | kochar | 1 |
67 | warme-pflaster | 3 |
68 | attendances | 89 |
69 | dispatches | 11 |
70 | cystoscopies | 16 |
71 | subterritories | 1 |
72 | supremes | 2 |
73 | secundines | 2 |
74 | revascularization-procedures | 1 |
75 | mmses | 1 |
76 | field-notes | 1 |
77 | supreme-fs | 1 |
78 | suctionings | 7 |
79 | measurings | 1 |
80 | vcugs | 16 |
81 | orasis | 1 |
82 | tele-diagnosis | 1 |
83 | bounce-backs | 1 |
84 | rechecks | 1 |
85 | 2-4weeks | 1 |
86 | certifications | 15 |
87 | creations | 4 |
88 | cohabitations | 3 |
89 | visitations | 3 |
90 | re-presentations | 6 |
91 | risks.evaluations | 1 |
92 | renovations | 4 |
93 | trips | 54 |
94 | check-ups | 114 |
95 | pickups | 2 |
96 | rsars | 1 |
97 | attenders | 90 |
98 | driggers | 1 |
99 | times-teachers | 1 |
100 | null-responders/relapsers | 1 |
101 | non-responders/relapsers | 1 |
102 | non-achievers | 4 |
103 | visits | 8,399 |
104 | videovisits | 1 |
105 | test-results | 2 |
106 | staff.participants | 1 |
107 | appointments | 652 |
108 | vists | 2 |
109 | faustus | 1 |
110 | sbp-cvs | 1 |
111 | levret | 1 |
112 | thelial-dependent | 1 |
113 | z350xt | 3 |
114 | supremext | 1 |
115 | f/u | 17 |
116 | 2.04±0.5au | 1 |
117 | 1/3-esv | 1 |
118 | tbbx | 18 |
119 | effort/accuracy | 1 |
120 | ofophthalmology | 1 |
121 | nontonsillectomy | 2 |
122 | inhalotherapy | 1 |
123 | affinity-cytochemistry | 1 |
124 | smear/biopsy | 1 |
125 | iassy | 1 |
126 | infratoxicity | 1 |
127 | flaherty | 1 |
128 | z250-fz | 1 |
129 | z350™ | 1 |
130 | fastrach™ | 11 |
131 | silorane® | 1 |
132 | monitoring® | 2 |